BNTX

NASD BioNTech SE Sponsored ADR
Oct 2, 2026 · 3:24 AM ET EOD Market Closed

$96.85 ↑ +0.00 (+0.00%) Trading Up from the previous close of $96.85, $2.64 below the day’s high of $99.49

YTD change
+1.73%
vs 20-day SMA
-2.05%
vs 200-day SMA
-0.84%

Price ranges

Previous day
$96.60 $99.49
open $97.59 close $96.85
-$0.74 (-0.76%)
Today
$96.60 $99.49
$96.85
Past week
$96.64 $100.21
from $98.46 now $96.85
-$1.61 (-1.64%)
Past month
$95.32 $105.46
from $101.95 now $96.85
-$5.10 (-5.00%)
This year
$79.52 $124.00
from $95.20 now $96.85
+$1.65 (+1.73%)

Price & Performance

+5.67 (+6.22%) / 6M

$83.01$95.03$107.04$119.06Apr 2Jul 2Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 79.1% away from all-time highs of $464.00
  • BNTX is up 2% since the beginning of the year
  • BNTX is down 5% over the past 12 months
  • BNTX is down 5% over the past 1 month
  • 1% of all BNTX investors are betting against BNTX

BNTX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -7.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-3.73361
Earnings momentum +544.5% Quarterly EPS growth
Quarterly change +544.5%

Valuation

P/E ratio N/A
Enterprise value $8.2B
Beta 1.42

Balance sheet & scale

IncomeN/A
Revenue$3.0B
Cash$16.9B
Debt$361.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $24.3B

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $407.27 -3.38%
MRNA Moderna, Inc. $188.94 -1.89%
RVMD Revolution Medicines, Inc. $205.89 +0.31%
ROIV Roivant Sciences Ltd. $35.50 -2.93%
MEDP Medpace Holdings, Inc. $598.08 -4.18%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.